4-127930800-G-T
Position:
Variant summary
Our verdict is Pathogenic. Variant got 14 ACMG points: 14P and 0B. PM2PP3_StrongPP5_Very_Strong
The NM_001371596.2(MFSD8):c.881C>A(p.Thr294Lys) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00000343 in 1,457,304 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★).
Frequency
Genomes: not found (cov: 33)
Exomes 𝑓: 0.0000034 ( 0 hom. )
Consequence
MFSD8
NM_001371596.2 missense
NM_001371596.2 missense
Scores
6
11
2
Clinical Significance
Conservation
PhyloP100: 8.51
Genes affected
MFSD8 (HGNC:28486): (major facilitator superfamily domain containing 8) This gene encodes a ubiquitous integral membrane protein that contains a transporter domain and a major facilitator superfamily (MFS) domain. Other members of the major facilitator superfamily transport small solutes through chemiosmotic ion gradients. The substrate transported by this protein is unknown. The protein likely localizes to lysosomal membranes. Mutations in this gene are correlated with a variant form of late infantile-onset neuronal ceroid lipofuscinoses (vLINCL). [provided by RefSeq, Oct 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Pathogenic. Variant got 14 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
PP3
MetaRNN computational evidence supports a deleterious effect, 0.961
PP5
Variant 4-127930800-G-T is Pathogenic according to our data. Variant chr4-127930800-G-T is described in ClinVar as [Likely_pathogenic]. Clinvar id is 1006.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr4-127930800-G-T is described in Lovd as [Likely_pathogenic]. Variant chr4-127930800-G-T is described in Lovd as [Pathogenic].
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MFSD8 | NM_001371596.2 | c.881C>A | p.Thr294Lys | missense_variant | 9/12 | ENST00000641686.2 | NP_001358525.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MFSD8 | ENST00000641686.2 | c.881C>A | p.Thr294Lys | missense_variant | 9/12 | NM_001371596.2 | ENSP00000493218.2 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD3 genomes
Cov.:
33
GnomAD3 exomes AF: 0.00000802 AC: 2AN: 249426Hom.: 0 AF XY: 0.00000742 AC XY: 1AN XY: 134718
GnomAD3 exomes
AF:
AC:
2
AN:
249426
Hom.:
AF XY:
AC XY:
1
AN XY:
134718
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00000343 AC: 5AN: 1457304Hom.: 0 Cov.: 31 AF XY: 0.00000414 AC XY: 3AN XY: 724652
GnomAD4 exome
AF:
AC:
5
AN:
1457304
Hom.:
Cov.:
31
AF XY:
AC XY:
3
AN XY:
724652
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome Cov.: 33
GnomAD4 genome
Cov.:
33
ClinVar
Significance: Pathogenic/Likely pathogenic
Submissions summary: Pathogenic:10
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
Neuronal ceroid lipofuscinosis 7 Pathogenic:6
Pathogenic, no assertion criteria provided | literature only | OMIM | Mar 01, 2009 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | MGZ Medical Genetics Center | Oct 22, 2021 | - - |
Likely pathogenic, criteria provided, single submitter | clinical testing | Institute of Human Genetics Munich, Klinikum Rechts Der Isar, TU München | Nov 16, 2017 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Nov 27, 2023 | This sequence change replaces threonine, which is neutral and polar, with lysine, which is basic and polar, at codon 294 of the MFSD8 protein (p.Thr294Lys). This variant is present in population databases (rs140948465, gnomAD 0.0009%). This missense change has been observed in individual(s) with clinical features of neuronal ceroid lipofuscinosis (PMID: 19177532, 19201763, 25439737). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. ClinVar contains an entry for this variant (Variation ID: 1006). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt MFSD8 protein function with a positive predictive value of 80%. Experimental studies have shown that this missense change affects MFSD8 function (PMID: 22668694). For these reasons, this variant has been classified as Pathogenic. - |
Pathogenic, criteria provided, single submitter | clinical testing | Blueprint Genetics | Aug 01, 2018 | - - |
Pathogenic, no assertion criteria provided | curation | GeneReviews | Aug 01, 2013 | - - |
not provided Pathogenic:2
Pathogenic, criteria provided, single submitter | clinical testing | GeneDx | Jun 11, 2024 | Published functional studies demonstrate a damaging effect with this variant significantly reducing MFSD8 protein function (PMID: 34910516); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Not observed at significant frequency in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 30548430, 35457110, 19177532, 34469436, 22668694, 34910516, 25439737, 19201763) - |
Likely pathogenic, criteria provided, single submitter | clinical testing | Revvity Omics, Revvity | Jun 14, 2021 | - - |
Inborn genetic diseases Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 10, 2018 | The p.T294K pathogenic mutation (also known as c.881C>A), located in coding exon 9 of the MFSD8 gene, results from a C to A substitution at nucleotide position 881. The threonine at codon 294 is replaced by lysine, an amino acid with similar properties. This mutation has been reported in the homozygous state in multiple individuals with neuronal ceroid lipofuscinosis (NCL) and has been suggested to be a founder mutation in the Roma Gypsy population (Kousi M et al. Brain, 2009 Mar;132:810-9; (Aiello C et al. Hum. Mutat., 2009 Mar;30:E530-40). This mutation was also reported with a splice site variant in trans in an individual with NCL (Craiu D et al. Eur. J. Paediatr. Neurol., 2015 Jan;19:78-86). In COS7 cells, this mutation altered Ctsl-mediated proteolytic cleavage (Steenhuis P et al. Biochim. Biophys. Acta, 2012 Oct;1822:1617-28). Based on the supporting evidence, this alteration is interpreted as a disease-causing mutation. - |
Late-infantile neuronal ceroid lipofuscinosis Pathogenic:1
Pathogenic, no assertion criteria provided | clinical testing | Natera, Inc. | Oct 01, 2020 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
BayesDel_addAF
Pathogenic
D
BayesDel_noAF
Pathogenic
CADD
Pathogenic
DANN
Uncertain
DEOGEN2
Uncertain
D;D;.;.;.;.;.;.;.;.;.;.;.;.
Eigen
Uncertain
Eigen_PC
Uncertain
FATHMM_MKL
Pathogenic
D
LIST_S2
Uncertain
.;.;D;D;D;.;D;D;D;D;D;D;D;D
M_CAP
Benign
D
MetaRNN
Pathogenic
D;D;D;D;D;D;D;D;D;D;D;D;D;D
MetaSVM
Uncertain
T
MutationAssessor
Uncertain
M;M;.;.;.;.;.;.;.;.;.;.;.;.
PrimateAI
Uncertain
T
PROVEAN
Pathogenic
.;D;.;.;.;.;.;.;.;.;.;.;.;.
REVEL
Uncertain
Sift
Uncertain
.;D;.;.;.;.;.;.;.;.;.;.;.;.
Sift4G
Uncertain
.;D;.;.;.;.;.;.;.;.;.;.;.;.
Polyphen
D;D;.;.;.;.;.;.;.;.;.;.;.;.
Vest4
0.88
MutPred
Gain of ubiquitination at T294 (P = 0.0311);Gain of ubiquitination at T294 (P = 0.0311);.;.;.;.;.;.;Gain of ubiquitination at T294 (P = 0.0311);.;.;.;Gain of ubiquitination at T294 (P = 0.0311);.;
MVP
0.82
MPC
0.52
ClinPred
D
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at